carbapenems has been researched along with Disease, Pulmonary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Dartois, V; Dick, T; Negatu, DA; Zimmerman, MD | 1 |
| Gao, E; Guo, J; Jiang, L; Li, S; Liu, Z; Xu, S | 1 |
| Kauffman, CA; Leavens, J; Miceli, MH; Steinbrink, J | 1 |
| Anderson, KF; Banach, DB; Calfee, DP; Kitchel, B; LaBombardi, V; Patel, G; Phillips, M; Poliansky Blash, S; Sharma, S; Srinivasan, A; Swaminathan, M | 1 |
| Apisarnthanarak, A; Bhooanusas, N; Mundy, LM; Yaprasert, A | 1 |
| Cerniauskiene, K; Dambrauskiene, A; Rimdeika, R; Sakalauskas, R; Vitkauskiene, A | 1 |
| Amyes, SG | 1 |
| Edwards, JR; Nairn, K; Williams, S | 1 |
| Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
1 review(s) available for carbapenems and Disease, Pulmonary
| Article | Year |
|---|---|
Nocardiosis in patients with nephrotic syndrome: a retrospective analysis of 11 cases and a literature review.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Fever; Glucocorticoids; Humans; Lung Diseases; Male; Middle Aged; Nephrotic Syndrome; Nocardia; Nocardia Infections; Pleural Effusion; Procalcitonin; Retrospective Studies; Subcutaneous Tissue; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2020 |
8 other study(ies) available for carbapenems and Disease, Pulmonary
| Article | Year |
|---|---|
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus | 2022 |
Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Immunocompromised Host; Lung Diseases; Male; Middle Aged; Nocardia; Nocardia Infections; Retrospective Studies; Risk Factors; Transplantation; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Female; Hospitals, University; Hospitals, Urban; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Middle Aged; New York City; Prevalence; Respiration, Artificial; Risk Factors; Young Adult | 2013 |
Carbapenem de-escalation therapy in a resource-limited setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Female; Gentian Violet; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lung Diseases; Male; Middle Aged; Phenazines; Referral and Consultation; Shock, Septic; Thailand; Urinary Tract Infections; Young Adult | 2013 |
Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Analysis of Variance; Anti-Bacterial Agents; Carbapenems; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
Strategies and options for minimizing resistance emergence in pulmonary infections.
Topics: Acinetobacter; Anti-Infective Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Hospitals; Humans; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Scotland; Streptococcus pneumoniae | 1998 |
Therapeutic activity of meropenem in experimental infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Escherichia coli Infections; Guinea Pigs; Immunosuppression Therapy; Lung Diseases; Male; Meropenem; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas Infections; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |